OTCMKTS:SHTDY Sinopharm Group (SHTDY) Stock Price, News & Analysis $9.40 -0.11 (-1.20%) As of 03:55 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividend About Sinopharm Group Stock (OTCMKTS:SHTDY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Sinopharm Group alerts:Sign Up Key Stats Today's Range$9.25▼$9.4150-Day Range$9.33▼$11.2352-Week Range$9.00▼$14.87Volume91,281 shsAverage Volume106,871 shsMarket CapitalizationN/AP/E Ratio1.88Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Sinopharm Group Co., Ltd. is a China-based healthcare company focused primarily on pharmaceutical and medical product distribution. Through its distribution network, the company supplies prescription medicines, over-the-counter drugs, traditional Chinese medicines, medical devices and other healthcare products to hospitals, pharmacies, clinics and other healthcare institutions. The company also operates pharmaceutical retail businesses and provides related supply-chain, logistics and healthcare services. Its operations support the procurement, warehousing and delivery of medicines and medical products, while affiliated businesses are involved in pharmaceutical manufacturing and other healthcare activities. Sinopharm Group serves customers throughout mainland China and is part of China National Pharmaceutical Group Corporation, commonly known as Sinopharm, one of China's major state-owned healthcare enterprises. The company is headquartered in Shanghai and its shares are listed on the Hong Kong Stock Exchange, with American depositary shares traded over the counter in the United States.AI Generated. May Contain Errors. Read More Receive SHTDY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sinopharm Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SHTDY Stock News HeadlinesSinopharm Group Co. Ltd. (OTCMKTS:SHTDY) Shares Shorted: Short Interest Up 734.7% in SeptemberOctober 11 at 1:00 PM | americanbankingnews.comSHTDY - Sinopharm Group Co. Ltd.August 26, 2026 | seekingalpha.comMy next big call (under $1)Bitcoin is down. Fear is high. Most investors are sitting on their hands. That's exactly when my biggest winners have been found: KDA: 17,556% ... PRE: 3,900% ... OCEAN: 2,650% ... ALBT: 1,933% Every single one was called to our community before the big move happened. So today, while everyone else is scared, I'm making my next big call.October 12 at 1:00 AM | Crypto 101 Media (Ad)SINOPHARM GRP CO UNSP/ADR by Sinopharm Group Co. Ltd. Stock Short Interest Report | OTC:SHTDY | BenzingaJuly 23, 2026 | benzinga.comSinopharm Group Announces Executive Director ChangesNovember 6, 2025 | msn.comSinopharm Group Schedules Board Meeting to Review Interim ResultsAugust 13, 2025 | msn.comSinopharm Group Co. Ltd. ADR (SHTDY) Stock Price Today - WSJJuly 17, 2025 | wsj.comSinopharm Group Updates Final Dividend Distribution for 2024June 12, 2025 | tipranks.comSee More Headlines SHTDY Stock Analysis - Frequently Asked Questions How have SHTDY shares performed this year? Sinopharm Group's stock was trading at $12.40 at the beginning of the year. Since then, SHTDY shares have decreased by 24.2% and is now trading at $9.3960. How do I buy shares of Sinopharm Group? Shares of SHTDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryN/A Current SymbolOTCMKTS:SHTDY CIK1556605 Webwww.sinopharmgroup.com.cn Phone86-21-2305-2666FaxN/AEmployees94,910Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio1.88 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (OTCMKTS:SHTDY) was last updated on 10/12/2026 by MarketBeat.com Staff. From Our PartnersPalantir and Wall Street are in on it…Palantir just signed a major AI deal with a company most investors have never heard of. Wall Street has pou...Monument Traders Alliance | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredMy biggest prediction yet?!James Altucher called Facebook's rise past 100 billion dollars in 2007 and Apple's run to a trillion years lat...Paradigm Press | SponsoredThe AI Stock to Keep an Eye on Before Election Day (See Why)In 2019, Charles Mizrahi named Marvell Technology his top AI pick. It's since climbed 1300 percent. Now he'...Prosperity Research | SponsoredTrump To Relaunch USD?President Trump's summit with Xi Jinping drew headlines for tariffs and trade truces, but the real story may b...Porter & Company | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinopharm Group Co. Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sinopharm Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SHTDY Stock Alerts